b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31679427</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>22</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>22</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1524-4563</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>74</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>12</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Hypertension (Dallas, Tex. : 1979)</Title>\n                <ISOAbbreviation>Hypertension</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Potential of Stratified Medicine for High Blood Pressure Management: A Modeling Study Using NHANES Survey Data.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1420-1427</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1161/HYPERTENSIONAHA.119.13749</ELocationID>\n            <Abstract>\n                <AbstractText>The 2017 American College of Cardiology/American Heart Association hypertension guidelines lowered the thresholds for defining and treating hypertension. However, the SPRINT trial showed substantial heterogeneity in benefits and harms of intensive antihypertensive treatment depending on patients\' characteristics. We aimed at illustrating the potential gains of personalizing intensive antihypertensive treatment. Using the US National Health and Nutrition Examination Survey 2011 to 2014 (n=2067), and prediction models derived from the SPRINT trial, we computed expected benefits and harms of intensive antihypertensive treatment for individuals aged 50 or more. We compared 2 interventions: (1) intensive antihypertensive treatment for all individuals meeting the 2017 American College of Cardiology/American Heart Association thresholds and (2) a stratified medicine strategy excluding from intensive treatment individuals with predicted unfavorable benefit-risk. Outcome measures were model-predicted 5-year risk of cardiovascular events or death (myocardial infarction, acute coronary, stroke, acute decompensated heart failure, and cardiovascular-related death), and severe adverse events (hypotension, syncope, electrolyte abnormalities, bradycardia, and acute kidney injury). Per 2017 American College of Cardiology/American Heart Association guidelines, 40.1 million (39.2%) US individuals aged 50 or more should initiate or intensify antihypertensive treatment, thereby preventing cardiovascular events for 795\xe2\x80\x89000 individuals and inducing severe adverse events for 848\xe2\x80\x89000 over 5 years. A stratified treatment strategy could decrease the number of individuals treated by 21.2 million (52.9%) and reduce the number of individuals with severe adverse events by 38.3%, with 11.7% fewer individuals with cardiovascular events prevented. Personalizing antihypertensive treatment according to predicted benefits and harms could spare treatment for more than half individuals while reducing harms 3\xc3\x97 more than benefits.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Porcher</LastName>\n                    <ForeName>Rapha\xc3\xabl</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the Assistance Publique-H\xc3\xb4pitaux de Paris (AP-HP), H\xc3\xb4pital H\xc3\xb4tel-Dieu, Center for Clinical Epidemiology, Paris, France (R.P., V.-T.T., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR1153 Epidemiology and Statistics Sorbonne Paris Cit\xc3\xa9 Research Center (CRESS), Team METHODS, Paris, France (R.P., V.-T.T., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France (R.P., J.B., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tran</LastName>\n                    <ForeName>Viet-Thi</ForeName>\n                    <Initials>VT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the Assistance Publique-H\xc3\xb4pitaux de Paris (AP-HP), H\xc3\xb4pital H\xc3\xb4tel-Dieu, Center for Clinical Epidemiology, Paris, France (R.P., V.-T.T., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR1153 Epidemiology and Statistics Sorbonne Paris Cit\xc3\xa9 Research Center (CRESS), Team METHODS, Paris, France (R.P., V.-T.T., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Blacher</LastName>\n                    <ForeName>Jacques</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France (R.P., J.B., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique-H\xc3\xb4pitaux de Paris (AP-HP), H\xc3\xb4pital H\xc3\xb4tel-Dieu, Centre de Diagnostic et de Th\xc3\xa9rapeutique, Paris, France (J.B.).</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR1153 Epidemiology and Statistics Sorbonne Paris Cit\xc3\xa9 Research Center (CRESS), Team EREN, Bobigny, France (J.B.).</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ravaud</LastName>\n                    <ForeName>Philippe</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the Assistance Publique-H\xc3\xb4pitaux de Paris (AP-HP), H\xc3\xb4pital H\xc3\xb4tel-Dieu, Center for Clinical Epidemiology, Paris, France (R.P., V.-T.T., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR1153 Epidemiology and Statistics Sorbonne Paris Cit\xc3\xa9 Research Center (CRESS), Team METHODS, Paris, France (R.P., V.-T.T., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France (R.P., J.B., P.R.).</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Columbia University, Mailman School of Public Health, Department of Epidemiology, NY (P.R.).</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>04</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Hypertension</MedlineTA>\n            <NlmUniqueID>7906255</NlmUniqueID>\n            <ISSNLinking>0194-911X</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="CommentIn">\n                <RefSource>Hypertension. 2019 Dec;74(6):1302-1304</RefSource>\n                <PMID Version="1">31679430</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000572" MajorTopicYN="N">American Heart Association</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001795" MajorTopicYN="N">Blood Pressure Determination</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009749" MajorTopicYN="N">Nutrition Surveys</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D040242" MajorTopicYN="N">Risk Reduction Behavior</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">blood pressure</Keyword>\n            <Keyword MajorTopicYN="Y">cardiology</Keyword>\n            <Keyword MajorTopicYN="Y">decision support techniques</Keyword>\n            <Keyword MajorTopicYN="Y">hypertension</Keyword>\n            <Keyword MajorTopicYN="Y">models, statistical</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>5</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31679427</ArticleId>\n            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.119.13749</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'